nodes	percent_of_prediction	percent_of_DWPC	metapath
Acenocoumarol—CYP1A2—Carmustine—lymphatic system cancer	0.213	0.264	CbGbCtD
Acenocoumarol—CYP2C19—Teniposide—lymphatic system cancer	0.155	0.192	CbGbCtD
Acenocoumarol—CYP2C9—Teniposide—lymphatic system cancer	0.129	0.16	CbGbCtD
Acenocoumarol—CYP3A4—Cytarabine—lymphatic system cancer	0.076	0.0944	CbGbCtD
Acenocoumarol—CYP3A4—Teniposide—lymphatic system cancer	0.0749	0.093	CbGbCtD
Acenocoumarol—ALB—Methotrexate—lymphatic system cancer	0.0696	0.0865	CbGbCtD
Acenocoumarol—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0524	0.065	CbGbCtD
Acenocoumarol—CYP3A4—Vincristine—lymphatic system cancer	0.036	0.0448	CbGbCtD
Acenocoumarol—Skin necrosis—Carmustine—lymphatic system cancer	0.0107	0.0552	CcSEcCtD
Acenocoumarol—Neoplasm—Teniposide—lymphatic system cancer	0.00604	0.031	CcSEcCtD
Acenocoumarol—Skin necrosis—Methotrexate—lymphatic system cancer	0.00498	0.0256	CcSEcCtD
Acenocoumarol—Menorrhagia—Vincristine—lymphatic system cancer	0.00484	0.0249	CcSEcCtD
Acenocoumarol—Menorrhagia—Mitoxantrone—lymphatic system cancer	0.00472	0.0242	CcSEcCtD
Acenocoumarol—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00457	0.0235	CcSEcCtD
Acenocoumarol—Ulcer—Bleomycin—lymphatic system cancer	0.00455	0.0234	CcSEcCtD
Acenocoumarol—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00455	0.0234	CcSEcCtD
Acenocoumarol—Skin exfoliation—Bleomycin—lymphatic system cancer	0.00411	0.0211	CcSEcCtD
Acenocoumarol—Alopecia—Mechlorethamine—lymphatic system cancer	0.00402	0.0206	CcSEcCtD
Acenocoumarol—Ulcer—Mitoxantrone—lymphatic system cancer	0.00369	0.019	CcSEcCtD
Acenocoumarol—Skin exfoliation—Carmustine—lymphatic system cancer	0.00359	0.0184	CcSEcCtD
Acenocoumarol—Appetite absent—Methotrexate—lymphatic system cancer	0.0035	0.018	CcSEcCtD
Acenocoumarol—Neoplasm—Carmustine—lymphatic system cancer	0.0034	0.0174	CcSEcCtD
Acenocoumarol—Haemoglobin—Teniposide—lymphatic system cancer	0.00337	0.0173	CcSEcCtD
Acenocoumarol—Haemorrhage—Teniposide—lymphatic system cancer	0.00335	0.0172	CcSEcCtD
Acenocoumarol—Haematuria—Fludarabine—lymphatic system cancer	0.00313	0.0161	CcSEcCtD
Acenocoumarol—Alopecia—Teniposide—lymphatic system cancer	0.00296	0.0152	CcSEcCtD
Acenocoumarol—Haemoglobin—Fludarabine—lymphatic system cancer	0.00296	0.0152	CcSEcCtD
Acenocoumarol—Haemorrhage—Fludarabine—lymphatic system cancer	0.00295	0.0151	CcSEcCtD
Acenocoumarol—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00281	0.0144	CcSEcCtD
Acenocoumarol—Alopecia—Fludarabine—lymphatic system cancer	0.0026	0.0134	CcSEcCtD
Acenocoumarol—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00238	0.0122	CcSEcCtD
Acenocoumarol—Haematuria—Bleomycin—lymphatic system cancer	0.0023	0.0118	CcSEcCtD
Acenocoumarol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00221	0.0114	CcSEcCtD
Acenocoumarol—Haemoglobin—Bleomycin—lymphatic system cancer	0.00217	0.0111	CcSEcCtD
Acenocoumarol—Haemorrhage—Bleomycin—lymphatic system cancer	0.00216	0.0111	CcSEcCtD
Acenocoumarol—Decreased appetite—Teniposide—lymphatic system cancer	0.00207	0.0106	CcSEcCtD
Acenocoumarol—Vomiting—Mechlorethamine—lymphatic system cancer	0.00205	0.0105	CcSEcCtD
Acenocoumarol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00204	0.0105	CcSEcCtD
Acenocoumarol—Nausea—Mechlorethamine—lymphatic system cancer	0.00192	0.00985	CcSEcCtD
Acenocoumarol—Alopecia—Bleomycin—lymphatic system cancer	0.00191	0.0098	CcSEcCtD
Acenocoumarol—Haemoglobin—Carmustine—lymphatic system cancer	0.0019	0.00973	CcSEcCtD
Acenocoumarol—Urticaria—Teniposide—lymphatic system cancer	0.00189	0.00972	CcSEcCtD
Acenocoumarol—Haemorrhage—Carmustine—lymphatic system cancer	0.00189	0.00968	CcSEcCtD
Acenocoumarol—Body temperature increased—Teniposide—lymphatic system cancer	0.00188	0.00967	CcSEcCtD
Acenocoumarol—Haematuria—Mitoxantrone—lymphatic system cancer	0.00186	0.00956	CcSEcCtD
Acenocoumarol—Ulcer—Methotrexate—lymphatic system cancer	0.00184	0.00944	CcSEcCtD
Acenocoumarol—Decreased appetite—Fludarabine—lymphatic system cancer	0.00182	0.00934	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00181	0.00928	CcSEcCtD
Acenocoumarol—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00176	0.00905	CcSEcCtD
Acenocoumarol—Hypersensitivity—Teniposide—lymphatic system cancer	0.00176	0.00901	CcSEcCtD
Acenocoumarol—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00175	0.009	CcSEcCtD
Acenocoumarol—Melaena—Methotrexate—lymphatic system cancer	0.0017	0.00872	CcSEcCtD
Acenocoumarol—Alopecia—Carmustine—lymphatic system cancer	0.00167	0.00856	CcSEcCtD
Acenocoumarol—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00166	0.00853	CcSEcCtD
Acenocoumarol—Body temperature increased—Fludarabine—lymphatic system cancer	0.00166	0.0085	CcSEcCtD
Acenocoumarol—Diarrhoea—Teniposide—lymphatic system cancer	0.00163	0.00837	CcSEcCtD
Acenocoumarol—Alopecia—Vincristine—lymphatic system cancer	0.00159	0.00817	CcSEcCtD
Acenocoumarol—Neoplasm—Methotrexate—lymphatic system cancer	0.00157	0.00808	CcSEcCtD
Acenocoumarol—Alopecia—Mitoxantrone—lymphatic system cancer	0.00155	0.00796	CcSEcCtD
Acenocoumarol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00154	0.00792	CcSEcCtD
Acenocoumarol—Vomiting—Teniposide—lymphatic system cancer	0.00151	0.00778	CcSEcCtD
Acenocoumarol—Dermatitis—Teniposide—lymphatic system cancer	0.0015	0.0077	CcSEcCtD
Acenocoumarol—Diarrhoea—Fludarabine—lymphatic system cancer	0.00143	0.00735	CcSEcCtD
Acenocoumarol—Nausea—Teniposide—lymphatic system cancer	0.00142	0.00726	CcSEcCtD
Acenocoumarol—Decreased appetite—Bleomycin—lymphatic system cancer	0.00133	0.00685	CcSEcCtD
Acenocoumarol—Vomiting—Fludarabine—lymphatic system cancer	0.00133	0.00683	CcSEcCtD
Acenocoumarol—Dermatitis—Fludarabine—lymphatic system cancer	0.00132	0.00677	CcSEcCtD
Acenocoumarol—Nausea—Fludarabine—lymphatic system cancer	0.00124	0.00639	CcSEcCtD
Acenocoumarol—Urticaria—Bleomycin—lymphatic system cancer	0.00122	0.00626	CcSEcCtD
Acenocoumarol—Body temperature increased—Bleomycin—lymphatic system cancer	0.00121	0.00623	CcSEcCtD
Acenocoumarol—Decreased appetite—Carmustine—lymphatic system cancer	0.00116	0.00598	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00116	0.00594	CcSEcCtD
Acenocoumarol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00113	0.00581	CcSEcCtD
Acenocoumarol—Decreased appetite—Vincristine—lymphatic system cancer	0.00111	0.00571	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.0011	0.00567	CcSEcCtD
Acenocoumarol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00108	0.00556	CcSEcCtD
Acenocoumarol—Body temperature increased—Carmustine—lymphatic system cancer	0.00106	0.00544	CcSEcCtD
Acenocoumarol—Body temperature increased—Vincristine—lymphatic system cancer	0.00101	0.00519	CcSEcCtD
Acenocoumarol—Urticaria—Mitoxantrone—lymphatic system cancer	0.00099	0.00508	CcSEcCtD
Acenocoumarol—Hypersensitivity—Carmustine—lymphatic system cancer	0.000987	0.00507	CcSEcCtD
Acenocoumarol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000985	0.00506	CcSEcCtD
Acenocoumarol—Vomiting—Bleomycin—lymphatic system cancer	0.000976	0.00501	CcSEcCtD
Acenocoumarol—Dermatitis—Bleomycin—lymphatic system cancer	0.000967	0.00496	CcSEcCtD
Acenocoumarol—Hypersensitivity—Vincristine—lymphatic system cancer	0.000942	0.00484	CcSEcCtD
Acenocoumarol—Haematuria—Methotrexate—lymphatic system cancer	0.000928	0.00476	CcSEcCtD
Acenocoumarol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000918	0.00471	CcSEcCtD
Acenocoumarol—Diarrhoea—Carmustine—lymphatic system cancer	0.000917	0.00471	CcSEcCtD
Acenocoumarol—Nausea—Bleomycin—lymphatic system cancer	0.000912	0.00468	CcSEcCtD
Acenocoumarol—Haemoglobin—Methotrexate—lymphatic system cancer	0.000878	0.00451	CcSEcCtD
Acenocoumarol—Diarrhoea—Vincristine—lymphatic system cancer	0.000875	0.00449	CcSEcCtD
Acenocoumarol—Haemorrhage—Methotrexate—lymphatic system cancer	0.000874	0.00449	CcSEcCtD
Acenocoumarol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000852	0.00438	CcSEcCtD
Acenocoumarol—Vomiting—Carmustine—lymphatic system cancer	0.000852	0.00437	CcSEcCtD
Acenocoumarol—Dermatitis—Carmustine—lymphatic system cancer	0.000844	0.00433	CcSEcCtD
Acenocoumarol—Vomiting—Vincristine—lymphatic system cancer	0.000813	0.00418	CcSEcCtD
Acenocoumarol—Dermatitis—Vincristine—lymphatic system cancer	0.000806	0.00414	CcSEcCtD
Acenocoumarol—Nausea—Carmustine—lymphatic system cancer	0.000796	0.00409	CcSEcCtD
Acenocoumarol—Vomiting—Mitoxantrone—lymphatic system cancer	0.000792	0.00407	CcSEcCtD
Acenocoumarol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000785	0.00403	CcSEcCtD
Acenocoumarol—Alopecia—Methotrexate—lymphatic system cancer	0.000772	0.00396	CcSEcCtD
Acenocoumarol—Nausea—Vincristine—lymphatic system cancer	0.00076	0.0039	CcSEcCtD
Acenocoumarol—Nausea—Mitoxantrone—lymphatic system cancer	0.00074	0.0038	CcSEcCtD
Acenocoumarol—Decreased appetite—Methotrexate—lymphatic system cancer	0.00054	0.00277	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000536	0.00275	CcSEcCtD
Acenocoumarol—Urticaria—Methotrexate—lymphatic system cancer	0.000493	0.00253	CcSEcCtD
Acenocoumarol—Body temperature increased—Methotrexate—lymphatic system cancer	0.000491	0.00252	CcSEcCtD
Acenocoumarol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000457	0.00235	CcSEcCtD
Acenocoumarol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000425	0.00218	CcSEcCtD
Acenocoumarol—Vomiting—Methotrexate—lymphatic system cancer	0.000395	0.00203	CcSEcCtD
Acenocoumarol—Dermatitis—Methotrexate—lymphatic system cancer	0.000391	0.00201	CcSEcCtD
Acenocoumarol—Nausea—Methotrexate—lymphatic system cancer	0.000369	0.00189	CcSEcCtD
